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Introduction
Acute kidney injury (AKI) is a common condition and, 
even when mild, is associated with mortality and mor-
bidity [1]. During critical illness, AKI is most frequently 
observed in the settings of sepsis and after surgery [2]. In 
these contexts, ﬂ uid resuscitation (FR) is almost 
universally employed to maintain or increase cardiac 
output and organ perfusion. Creatinine-related variables 
and urine output are often targeted during resuscitation 
as surrogates of adequacy of organ perfu sion in general 
and to prevent AKI. Understanding the relationship 
between FR, resuscitation goals and AKI is therefore 
important to develop a rational approach to FR strategies 
in acute illness.
From a renal standpoint, ﬂ uid therapy is aimed at 
restor ing systemic blood pressure (a major determinant 
of renal perfusion pressure) and cardiac output (a pre-
requisite for adequate renal blood ﬂ ow (RBF)). Fluid 
administration aimed at restoring systemic blood 
pressure works mechanistically by increasing the preload 
and stroke volume. In hypovolaemia, ﬂ uid therapy restores 
right ventricular end-diastolic volume and is an essential 
ﬁ rst step in resuscitation. Unfortunately, con ven tional 
goals of FR and restoration of blood pressure, central 
venous pressure and/or urine output are only indirect 
measures of cardiac output and are much less indicative 
of the restoration of adequate organ blood ﬂ ow. Similarly, 
the eﬀ ects of critical illness, pre-existing chronic disease 
and pharmacotherapy can unpredictably alter physio logi-
cal determinants of ﬂ uid responsiveness. Th ese eﬀ ects 
make the eﬀ ects of FR variable in extent and duration, 
and make the assessment of adequacy of FR very 
challenging.
Evidence regarding FR and outcomes in critical illness 
and after major surgery can be divided into two cate-
gories. Firstly, a considerable body of evidence suggests 
that positive ﬂ uid balances are associated with increased 
postoperative complications [3,4], while more conserva-
tive intravenous ﬂ uid administration strategies do not 
seem harmful to renal function [5]. Similarly in critical 
illness, more positive ﬂ uid balances have been associated 
with the development of AKI [6] and with worse out-
comes if AKI develops [6,7]. Secondly, use of goal-
directed therapy (GDT) strategies for perioperative 
haemo dynamic optimisation have been associated with 
Abstract
Intravenous fl uids are widely administered to maintain 
renal perfusion and prevent acute kidney injury (AKI). 
However, fl uid overload is of concern during AKI. 
Using the Pubmed database (up to October 2011) we 
identifi ed all randomised controlled studies of goal-
directed therapy (GDT)-based fl uid resuscitation (FR) 
reporting renal outcomes and documenting fl uid 
given during perioperative care. In 24 perioperative 
studies, GDT was associated with decreased risk 
of postoperative AKI (odds ratio (OR) = 0.59, 95% 
confi dence interval (CI) = 0.39 to 0.89) but additional 
fl uid given was limited (median: 555 ml). Moreover, 
the decrease in AKI was greatest (OR = 0.47, 95% 
CI = 0.29 to 0.76) in the 10 studies where FR was the 
same between GDT and control groups. Inotropic drug 
use in GDT patients was associated with decreased 
AKI (OR = 0.52, 95% CI = 0.34 to 0.80, P = 0.003), 
whereas studies not involving inotropic drugs found 
no eff ect (OR = 0.75, 95% CI = 0.37 to 1.53, P = 0.43). 
The greatest protection from AKI occurred in patients 
with no diff erence in total fl uid delivery and use of 
inotropes (OR = 0.46, 95% CI = 0.27 to 0.76, P = 0.0036). 
GDT-based FR may decrease AKI in surgical patients; 
however, this eff ect requires little overall FR and 
appears most eff ective when supported by inotropic 
drugs.
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decreased surgical complications [3,8,9] and reduced risk 
of postoperative AKI [10]. GDT strategies involve the use 
of intensive monitoring and speciﬁ c haemodynamic 
targets to guide early aggressive ﬂ uid and/or vasoactive 
drug administration. While individually persuasive, 
collect ively these two lines of evidence appear diﬃ  cult to 
reconcile. On the one hand, ﬂ uid overload appears harm-
ful overall, and to the kidney in particular; on the other 
hand, goal-directed FR reduces mortality, morbidity and 
renal dysfunction. Th e evidence base for both of these 
conclusions is strongest in surgery, and consequently 
perioperative resuscitation was chosen as the setting to 
best explore this issue.
Th is seeming conﬂ ict in evidence may be the cause of 
controversy surrounding the extent of FR in patients at 
risk of AKI. Yet, without knowledge of the relative timing 
of onset, duration and quantity of ﬂ uid given during 
GDT-FR compared with the current standard of care, it is 
impossible to gauge whether the apparent beneﬁ ts of 
more conservative FR and those of goal-directed haemo-
dynamic therapy are truly in opposition. Accordingly, we 
conducted a systematic literature review and meta-
analysis of controlled trials of goal-directed resuscitation 
protocols in the settings of surgery. Our focus was on 
AKI and the quantity of ﬂ uid administered. We hypo-
thesised that the beneﬁ cial eﬀ ects of GDT on subsequent 
renal function are related to the amount of additional 
ﬂ uid given during GDT compared with control patients, 
treated according to the standard of care.
Methods
Aims
We aimed to identify and review studies describ ing 
haemo dynamically targeted FR during GDT for peri-
operative optimisation. In particular, we aimed to deter-
mine whether such protocols have a beneﬁ cial eﬀ ect on 
renal function and to what extent this treatment involves 
increased ﬂ uid administration in comparison with 
control groups treated according to the standard of care.
Electronic search strategy
We interrogated the MEDLINE electronic reference 
database using a combination of search terms (Figure 1). 
In addition, bibliographies of known systematic reviews 
and retrieved articles were examined for references of 
potential relevance. Our wide search terms deﬁ ned a set 
of records containing randomised controlled trials 
(RCTs) of GDT in surgery; these abstracts were then 
manually examined to identify a subset of studies of 
potential relevance for manuscript retrieval. Th ese publi-
cations were examined manually for accordance with our 
inclusion criteria. Additional checks were made to ensure 
none of these publications had been subject to retraction 
[11].
Study inclusion criteria
Population
We considered only patients undergoing major surgery. 
Studies involving mixed populations of critically ill 
patients were excluded.
Intervention
GDT was deﬁ ned as monitoring of physiological 
measure ments related to adequacy of cardiac output, 
systemic oxygen delivery or ventricular preload and 
providing speciﬁ c therapy to target normal or supra-
normal values by FR alone or in combination with 
inotropic drugs. GDT was required to commence before 
or within 8 hours from commencement of surgery.
Between-group comparisons
We considered studies that reported the eﬀ ects of GDT 
versus standard haemodynamic therapy, with special 
emphasis on the comparisons of cumulative volumes of 
FR. We excluded RCTs with no diﬀ erence in, or no 
description of, ﬂ uid management strategies between 
groups, RCTs comparing diﬀ ering GDT protocols target-
ing the same physiological goal, or studies without 
predeﬁ ned end points. A speciﬁ c requirement was that 
studies needed to report a volumetric quantiﬁ cation of 
FR. We did not consider studies that examined the eﬀ ect 
of diﬀ ering maintenance ﬂ uid infusions in our main 
analysis.
Outcome
Studies were required to report a renal outcome measure 
that deﬁ ned AKI – this could be an absolute or relative 
change in serum creatinine or urea, a deﬁ ned period of 
oliguria, a need for renal replacement therapy for AKI or 
some combination of these.
Data collection
We collected data on the study participants, the setting, 
the timing and duration of the intervention, the deﬁ nition 
of AKI used, the method of physiological monitoring and 
the GDT protocol. We additionally examined indicators 
of study quality and reporting, including documentation 
of the method of randomisation, the extent of blinding 
and description of drop-outs based on the score proposed 
by Jadad and colleagues [12]. Finally, we documented the 
recorded volume of ﬂ uid administered and whether there 
were statistical diﬀ erences in these quantities.
To assess the volumes of ﬂ uid administered in the treat-
ment and control groups we calculated the diﬀ erence in 
the mean or median total ﬂ uid volume delivered between 
groups. When a total was not reported, we summed the 
mean or median volumes of crystalloids, colloid and 
blood products given during the protocol period in the 
GDT and control groups to estimate the total ﬂ uid 
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volume delivered in each group. We deﬁ ned studies 
employing a larger volume of FR during GDT as those 
demonstrating a statistically signiﬁ cant diﬀ erence 
between one or more types of ﬂ uid administered between 
groups during GDT. In addition, we excluded from our 
deﬁ nition any studies where the diﬀ erence in mean or 
median ﬂ uid adminis tration during the GDT protocol 
period was <500 ml, an arbitrary deﬁ nition of a clinically 
insigniﬁ cant diﬀ er ence in ﬂ uid administration between 
GDT and standard of care.
Statistical analysis
Meta-analysis was performed using R: A language and 
environment for statistical computing (R Foundation for 
Statistical Computing, Vienna, Austria [13]), utilising the 
packages meta, metafor and rmeta. As studies compared 
diﬀ ering interventions in diﬀ ering settings with diﬀ ering 
measures of renal function, a random eﬀ ects model was 
employed for all analyses. Th e eﬀ ect of GDT in the meta-
analysis of pooled studies was assessed by calculation of 
the odds ratio (OR) for AKI: OR <1 favoured GDT over 
the control group. Th e 95% conﬁ dence intervals (CIs) of 
the ORs and two-sided P values were calculated. A 
statistical diﬀ erence favouring or disfavouring GDT was 
considered to occur if the 95% CI failed to cross the 
OR = 1 line (equivalent to P <0.05).
Statistical heterogeneity [14] was assessed by calcu la-
tion of the I2 statistic and the Q-test [15,16]. Hetero-
geneity or inconsistency was considered signiﬁ  cant if 
I2 was >40% or if the P value for the Q-test was <0.1 [17]. 
When heterogeneity was present we assessed for outlier 
studies using a Galbraith plot [18] and repeated the analysis 
excluding the most signiﬁ cant outlier [19]. Our meta-
analysis was then repeated with subdivision by diﬀ erence 
in volume of FR between the GDT and control groups and 
by use or nonuse of inotropes in GDT protocols.
Results
Our search strategy on GDT in surgery identiﬁ ed 3,797 
abstracts or articles from which we examined 53 
Figure 1. Search strategy.
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potentially relevant manuscripts, ﬁ nding 24 articles that 
met our inclusion criteria [20-43] (Figure 2). All studies 
were in adult patients. Among the surgical studies not 
meeting the inclu sion criteria, three recent studies 
examined a more restric tive perioperative maintenance 
ﬂ uid infusion com bined with the use of GDT in one or 
both groups to facilitate a conservative maintenance ﬂ uid 
regimen [44-46]. While these studies were not directly 
comparable with standard GDT trials, they are of 
relevance to a discussion of the inter action between GDT 
and ﬂ uid balance and we elected to examine these 
investigations in a separate analysis.
Th e study details, population, size and quality indica-
tors are presented in Table 1; 15 of 24 studies had a Jadad 
score of 3. Blinding is inherently diﬃ  cult when using a 
treatment intervention triggered by invasive monitoring, 
and most studies were unblinded or partially blinded; 
while the randomisation method and dropouts were 
generally well recorded. As most studies were of similar 
quality, we did not subdivide our analysis based on 
quality.
Analysis of details of GDT interventions and renal 
outcome measures are presented in Table  2 and ﬂ uid 
adminis tration during GDT is presented in Table  3; 
further details of individual ﬂ uids administered in these 
studies are provided in Additional ﬁ le  1. Diagnostic 
criteria for AKI varied widely from a deﬁ ned increment 
in serum creatinine from baseline or oliguria over a 
speciﬁ ed duration to a need for renal replacement 
therapy (Table 2); for two studies [37,38] renal outcome 
data not in the original trial publication were reported in 
a previous meta-analysis [10]. Given the large variation in 
deﬁ nition of AKI for studies of GDT in surgery, we 
performed a further sensitivity analysis considering only 
studies where AKI was deﬁ ned as an elevation of 
creatinine from baseline of ≤100% or an absolute rise in 
serum creatinine of ≤200 μmol/l, representing studies 
using creatinine criteria for AKI thus including patients 
with less severe postoperative renal dysfunction 
(approximat ing RIFLE risk or injury AKI).
Goal-directed therapy in surgery
Of the 24 included studies, 16 reported a statistically 
signiﬁ cant greater quantity of colloid, crystalloid or total 
ﬂ uid administered during GDT. In two studies the diﬀ er-
ence in ﬂ uid administration was statistically signiﬁ  cant 
but the total diﬀ erence in FR between the GDT and 
control groups during the study period was small 
(+241 ml and +450 ml), so these studies were reallocated 
to the equivalent volume of FR with GDT group [32,39]. 
Fourteen studies were thus deemed to involve a greater 
volume of FR during GDT, their median diﬀ erence in FR 
between the GDT and control groups being +1,247  ml 
(range 500 to 11,099 ml). In the 10 studies categorised as 
having no greater volume of total FR during GDT, the 
median diﬀ erence in FR was 10  ml (range –600 to 
+529 ml). Among all 24 studies, the median diﬀ erence in 
FR was +555 ml.
Overall, 13 studies employed inotropic drugs in some 
or all patients in the GDT group, 10 studies did not use 
inotropic drugs, and one study had two treatment arms – 
one arm involving infusion of dopexamine in addition to 
stroke-volume-directed ﬂ uid boluses, and the other arm 
involving stroke-volume-guided therapy alone [31] 
(Table 2). In the meta-analysis this study was included as 
a single study in the overall analysis and in the analysis 
based on ﬂ uid therapy, but was treated as two studies 
when dividing studies on the basis of inotropic use 
(Figure 3 and Table 4).
Overall, GDT in surgery was associated with a signiﬁ -
cantly lower incidence of AKI (OR = 0.59, 95% CI = 0.39 
to 0.89, P = 0.013; 24 studies, n = 2,763 patients) (Figure 3 
and Table 4). When subdividing by larger versus equiva-
lent ﬂ uid administered during GDT, studies involving 
equivalent overall ﬂ uid therapy were associated with a 
lower incidence of AKI (OR = 0.47, 95% CI = 0.29 to 0.76, 
Figure 2. Search results for studies examining goal-directed 
therapy in surgery reporting a renal outcome. GDT, goal-directed 
therapy.
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Table 1. Study settings, size and quality of studies of fl uid therapy
        Jadad
Author Year Country Population Number Blinded Randomised Dropouts score
Studies of GDT in surgery
Challand and colleagues [25] 2012 UK Major open or laparoscopic 
colorectal surgery
179 1 2 1 4
Cecconi and colleagues [24] 2011 Italy Elective total hip arthroplasty 40 1 2 1 3
Mayer and colleagues [35] 2010 Germany Major abdominal surgery 60 1 2 1 3
Jhanji and colleagues [31] 2010 UK Major gastrointestinal surgery 135 0 2 1 3
Forget and colleagues [28] 2010 Belgium Major abdominal surgery 82 0 1 1 2
Benes and colleagues [21] 2010 Czech Republic High-risk elective intra-abdominal 
surgery
120 1 2 1 4
Harten and colleagues [30] 2008 UK – Scotland Patients over the age of 50 
undergoing emergency 
abdominal surgery
29 0 2 1 3
Kapoor and colleagues [32] 2008 India Patients with EuroSCORE 
≥3 undergoing coronary 
artery bypass surgery under 
cardiopulmonary bypass
30 0 2 1 3
Donati and colleagues [27] 2007 Italy Major abdominal surgery 135 0 2 1 3
Lopes and colleagues [34] 2007 Brazil High-risk surgery 33 0 2 1 3
Chytra and colleagues [26] 2006 Czech Republic ICU admissions undergoing 
surgery for major trauma with 
expected blood loss >2 l
162 0 1 1 2
Wakeling and colleagues [42] 2006 UK Colorectal resection 128 0 2 1 3
Noblett and colleagues [37] 2006 UK Elective colorectal resection 108 2 1 1 4
Pearse and colleagues [38] 2005 UK High-risk general surgical patients 122 0 2 1 3
McKendry and colleagues [36] 2004 UK Cardiac surgery 174 0 2 1 3
Gan and colleagues [29] 2002 USA Major elective surgery with an 
anticipated blood loss >500 ml
100 0 2 1 3
Bonazzi and colleagues [23] 2002 Italy Infrarenal abdominal aortic 
aneurysm repair
100 0 2 0 2
Venn and colleagues [41] 2002 UK Proximal femoral fracture repair, 
age >65
90 0 2 1 3
Lobo and colleagues [33] 2000 Brazil Patients >60 years old and/or with 
chronic diseases of vital organs 
who underwent major elective 
surgery
37 0 2 1 3
Pölönen and colleagues [39] 2000 Finland Elective cardiac surgery 403 0 2 1 3
Wilson and colleagues [43] 1999 UK Patients undergoing major 
elective surgery who were at 
risk of developing postoperative 
complications
138 0 2 1 3
Valentine and colleagues [40] 1998 USA Aortic surgery 120 0 1 1 2
Bender and colleagues [20] 1997 USA Elective vascular surgery 104 0 1 1 2
Bishop and colleagues [22] 1995 USA Surgery for major trauma 125 0 1 1 2
Studies using GDT in surgery comparing restrictive vs. conservative maintenance fl uids
Lobo and colleagues [46] 2011 Brazil High-risk elective surgery 88 0 1 1 2
Futier and colleagues [44] 2011 France Major abdominal surgery 70 1 2 1 4
Jammer and colleagues [45] 2010 Norway Open colorectal and lower 
intestinal surgery
241 0 2 1 3
GDT, goal-directed therapy.
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Table 2. Goal-directed therapy strategies and renal outcome measures in studies
      Signifi cantly
  Timing of    larger fl uid
Study Goal intervention GDT monitor Intervention Renal outcome in GDT
Studies of GDT in surgery
Challand and 
colleagues [25]
SV optimisation Intraoperative Oesophageal 
Doppler
SV-guided 200 ml 
HES 6% boluses
Creatinine increase to >149% 
of baseline during fi rst 
postoperative week
Yes
Cecconi and 
colleagues [24]
Maximise SV and DO2I 
>600 ml/min/m2
Intraoperative 
and 1-hour 
postoperative
FloTrac/Vigileo SV-guided HES 
6% boluses ± 
dobutamine
Oliguria or AKI Yes
Mayer and 
colleagues [35]
CI >2.5 l/min/m2, SV 
variation <12%
Intraoperative FloTrac/Vigileo 250 to 500 ml 
colloid boluses ± 
dobutamine
UO <500 ml/day or required 
dialysis for acute renal failure
No
Jhanji and 
colleagues [31]
SV optimisation For 8 hours 
postoperative
Lidco Gelatin 250 ml 
to optimise SV ± 
dopexamine 
0.5 μg/kg/min
AKIN criteria AKI No
Forget and 
colleagues [28]
Pulse oximeter 
plethysmogram variability 
index <13%
Intraoperative Pulse oximeter 250 ml colloid 
boluses
Postoperative oliguria or RRT No
Benes and 
colleagues [21]
SV variation <10%, CI 
>2.5 l/min/m2
Intraoperative FloTrac/Vigileo 3 ml/kg colloid 
boluses ± 
dobutamine
AKI by POSSUM scoring 
(increase in blood urea 
>5 mmol/l from preoperative 
levels) or RRT
No
Harten and 
colleagues [30]
Pulse pressure variation 
<10%
Intraoperative Lidco Boluses of 250 ml 
of 6% HES if pulse 
pressure variation 
>10%
UO <500 ml/day or increase 
in SCr >30% from the 
preoperative level
Yes
Kapoor and 
colleagues [32]
CVP >6 mmHg, SVV <10%, 
CI 2.5 to 4.2 l/min/m2, 
ScvO2 >70%
For 8 hours 
postoperative
FloTrac and ScvO2 Colloid boluses 
inotropes and blood 
per protocol
Increase in SCr >150 μmol/l, 
UO <750 ml/24 hours
Noa
Donati and 
colleagues [27]
O2 ER <27% Intraoperative to 
24 hours
CVC, arterial line Colloid boluses ± 
dobutamine
SCr >2 mg/dl or need for RRT No
Lopes and 
colleagues [34]
Pulse pressure variation 
<10%
Intraoperative Arterial line Colloid boluses 6% 
HES
UO <500 ml/day or serum 
creatinine >170 μmol/l or 
dialysis for AKI
Yes
Chytra and 
colleagues [26]
SV optimisation with FTc 
0.35 to 0.4 seconds
12 hours 
postoperative
Oesophageal 
Doppler
Colloid boluses 250 
ml gelatin or 6% HES
Need for RRT Yes
Wakeling and 
colleagues [42]
SV optimisation Intraoperative Oesophageal 
Doppler
Gelatin colloid 
boluses
UO <500 ml/day or increase 
in SCr >30% from the 
preoperative level
Yes
Noblett and 
colleagues [37]
SV optimisation with FTc 
0.35 to 0.4 seconds
Intraoperative Oesophageal 
Doppler
6% HES boluses 7 or 
3 ml/kg 
Increase in SCr or need for 
RRT
No
Pearse and 
colleagues [38]
Optimise SV and DO2I 
>600 ml/min/m2
Postoperative 
8 hours
Lidco Gelatin boluses 
to optimise SV ± 
dopexamine
Need for RRT Yes
McKendry and 
colleagues [36]
Stroke index >35 ml/m2 Postoperative 
4 hours
Oesophageal 
Doppler
200 ml boluses 
blood or colloid
Need for RRT Yes
Gan and 
colleagues [29]
SV optimisation with FTc 
0.35 to 0.4 seconds
Intraoperative Oesophageal 
Doppler
200 ml boluses of 
6% HES
UO <500 ml/day or increase 
in SCr >30% from the 
preoperative level
Yes
Bonazzi and 
colleagues [23]
CI >3.0 l/min/m2, PAOP 10 
to 18 mmHg, SVR <1,450 
dyne × second/cm5, DO2I 
>600 ml/min/m2
Preoperative 
to 2 days 
postoperative
Pulmonary artery 
catheter
Fluid, blood, 
dobutamine
Oliguria requiring high-dose 
frusemide or RRT
Yes
Continued overleaf
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P = 0.0049; 10 studies, n = 1,268 patients) (Figure 3 and 
Table  4) whereas studies categorised as involving larger 
ﬂ uid administration during GDT were not associated 
with lower incidence (OR = 0.70, 95% CI = 0.35 to 1.41, 
P  =  0.32; 13 studies, n  =  1,462 patients); one study was 
excluded for heterogeneity [34].
Goal-directed therapy and inotropic drug use in surgery
Inotropic drug use in GDT patients was associated with a 
reduction in the incidence of postoperative AKI 
(OR = 0.52, 95% CI = 0.34 to 0.80, P = 0.003; 14 studies, 
n = 1,634 patients) (Figure 3 and Table 4) compared with 
studies not involving inotropic drugs (OR  =  0.75, 95% 
Table 2. Continued
      Signifi cantly
  Timing of    larger fl uid
Study Goal intervention GDT monitor Intervention Renal outcome in GDT
Studies of GDT in surgery (continued)
Venn and 
colleagues [41]
Two GDT groups: CVP 
>14 mmHg or SV 
optimisation with FTc 
>0.35 seconds
Intraoperative CVC or oesophageal 
Doppler
Gelatin boluses 100 
to 200 ml
UO <500 ml/day or increase 
in SCr >30% from the 
preoperative level
Yes
Lobo and 
colleagues [33]
DO2I >600 ml/min/m
2 Intraoperative to 
24 hours
Pulmonary artery 
catheter
Fluids, blood, 
inotropes
SCr >3.5 mg/dl or UO 
<500 ml/24 hours
No
Pölönen and 
colleagues [39]
ScvO2 >70% lactate 
<2 mM
8 hours 
postoperative
Pulmonary artery 
catheter
Fluids, blood, 
inotropes
Increase in SCr >1.7 mg/dl, 
UO <750 ml/24 hours
Noa
Wilson and 
colleagues [43]
DO2I >600 ml/min/m
2, 
PAOP >12 mmHg
Preoperative to 
12 to 24 hours 
postoperative
Pulmonary artery 
catheter
Fluids, blood 
dopexamine or 
adrenaline 
UO <0.5 ml/kg/hour for 
>3 hours or 50% rise in SCr
No
Valentine and 
colleagues [40]
CI >2.8 l/min/m2, PAOP 8 
to 15 mmHg, SVR <1,100 
dyne × second/cm5
>14 hours 
preoperative
Pulmonary artery 
catheter
Fluids, dobutamine, 
vasodilators
Need for RRT or oliguria 
>24 hours with doubling 
of SCr
Yes
Bender and 
colleagues [20]
CI >2.8, PAOP 8 to 
14 mmHg, SVR <1,100 
dyne × second/cm5
Preoperative 
to 16 hours 
postoperative
Pulmonary artery 
catheter
Fluids, blood, 
dopamine, 
vasodilators
Increase in SCr >1 mg/dl Yes
Bishop and 
colleagues [22]
CI >4.5 l/min/m2, 
DO2I >760 ml/min/m
2, 
VO2I >166 ml/min/m
2
Attain goal 
within 24 hours 
of admission 
and maintain for 
48 hours
Pulmonary artery 
catheter
Fluids, blood, 
dobutamine, 
vasodilators
SCr >2 mg/dl or twice 
baseline in CKD
Yes
Studies using GDT in surgery comparing restrictive vs. conservative maintenance fl uids
Lobo and 
colleagues [46]
DO2I >600 ml/min/m
2 Intraoperative 
and 8 hours 
postoperative
Lidco SV-guided gelatin 
bolus ± dobutamine 
in both groups. 
Maintenance fl uid 4 
vs. 12 ml/kg/hour
SCr ×2 upper limit of normal Yes
Futier and 
colleagues [44]
Variation in peak aortic 
fl ow velocity (ΔPV) <13%
Intraoperative Oesophageal 
Doppler
ΔPV-guided 
boluses of 6% HES 
in both groups. 
Maintenance 
crystalloid 6 vs. 
12 ml/kg/hour
UO <500 ml/day or increase 
in SCr >30% from the 
preoperative level or need for 
acute RRT
Yes
Jammer and 
colleagues [45]
ScVO2 >75% Intraoperative CVC Colloid boluses 
3 ml/kg HES in GDT 
group. Maintenance 
fl uid 100 ml/hour in 
GDT vs. 800 ml/hour 
in controls
SCr increase >33% Yes
Statistically signifi cant greater fl uid administration in goal-directed therapy (GDT) deemed clinically insignifi cant (diff erence <500 ml). AKI, acute kidney injury; AKIN, 
Acute Kidney Injury Network; CI, cardiac index; CKD, chronic kidney disease; CVP, central venous pressure; CVC, central venous catheter; DO2I, oxygen delivery index; 
FTc, corrected fl ow time; HES, hydroxyethyl starch; O2 ER, oxygen extraction ratio; PAOP, pulmonary artery occlusion pressure; POSSUM, Physiological and Operative 
Severity Score for the Enumeration of Mortality and Morbidity; RRT, renal replacement therapy; sCr, serum creatinine; ScvO2, central venous oxygen saturation; SV, 
stroke volume; SVR, stroke volume ratio; SVV, stroke volume variation; UO, urine output; VO2I, oxygen consumption index. FloTrac, Edwards Lifesciences, Irvine, CA, 
USA; Lidco, LiDCO Group, London, UK; Vigileo, Edwards Lifesciences, Irvine, CA, USA. aStatistically, but not clinically signifi cantly larger FR in GDT group (<500ml).
Prowle et al. Critical Care 2012, 16:230 
http://ccforum.com/content/16/4/230
Page 7 of 15
CI = 0.37 to 1.53, P = 0.43; 10 studies, n = 1,016 patients); 
one study was excluded for heterogeneity [34] (Figure 3 
and Table 4). Th e lowest incidence of postoperative AKI 
occurred in patients with equivalent total ﬂ uid delivery in 
a protocol involving inotropic drugs (OR  =  0.46, 95% 
CI  =  0.27 to 0.76, P  =  0.0036; eight studies, n  =  1,033 
patients) (Figure  3 and Table  4); however, only a small 
number of studies (three studies, 280 patients) without 
use of inotropic drugs had equivalent total ﬂ uid delivery 
in the treatment group, so the eﬀ ect in this group was 
diﬃ  cult to assess.
Goal-directed therapy involving restrictive fl uid strategies 
in surgery
Th ree studies involving GDT and more restrictive ﬂ uid 
management were identiﬁ ed (Table  1). Two of these 
studies involved GDT in both groups with diﬀ ering 
maintenance ﬂ uid rates during surgery, while one study 
Table 3. Total fl uid administration in studies of perioperative goal-directed fl uid therapy
                                          Total fl uid resuscitation
                                          during intervention (ml) Diff erence in mean
     or median fl uid
Study Year Intervention duration GDT Control resuscitation (ml)
Studies of GDT in surgery    
Challand and colleagues [25] 2012 Operation 5,278 4,046 1,232
Cecconi and colleagues [24] 2011 Operation + 1 hour 6,032 2,635 3,397
Mayer and colleagues [35] 2010 Operation 4,528 4,494 34
Jhanji and colleagues [31] without dopexamine 2010 8 hours 4,892 4,351 541
Jhanji and colleagues [31] with dopexamine   4,868  517
Forget and colleagues [28] 2010 Operation 2,394  2,918  –524
Benes and colleagues [21] 2010 Operation 3,746 3,729 17
Harten and colleagues [30] 2008 Operation 3,500 3,000 500
Kapoor and colleagues [32] 2008 Operation + 8 hours 330a 80a 250b
Donati and colleagues [27] 2007 Operation + 24 hours 4,391 4,285 106
Lopes and colleagues [34] 2007 Operation 4,618 1,694 2,924
Chytra and colleagues [26] 2006 8 hours 4,516 3,649 867
Wakeling and colleagues [42] 2006 Operation 5,000 4,500 500
Noblett and colleagues [37] 2006 Operation 3,638 3,834 –196
Pearse and colleagues [38] 2005 8 hours 2,962 2,164 798
McKendry and colleagues [36] 2004 4 hours 2,020 681 1,339
Gan and colleagues [29] 2002 Operation 5,420 4,775 645
Bonazzi and colleagues [23] 2002 Operation to postoperative day 2 11,130  9,130 2,000
Venn and colleagues [41] 2002 Operation 2,655 2,075 580
Lobo and colleagues [33] 2000 24 hours 6,600 7,200 –600
Pölönen and colleagues [39] 2000 8 hours 3,193 2,772 421b
Wilson and colleagues [43] 1999 Operation + 12 hours 3,200 3,500 –300
Valentine and colleagues [40] 1998 14 hours preoperative + operation 8,650 6,710 1,940
Bender and colleagues [20] 1997 Operation + 16 hours 5,137 3,789 1,348
Bishop and colleagues [22] 1995 Preoperative and intraoperative 21,975c 10,876c 11,099
Studies using GDT in surgery comparing restrictive vs. conservative maintenance fl uid
Lobo and colleagues [46] 2011 Operation + 8 hours 3,517 5,250 –1,733
Futier and colleagues [44] 2011 Operation 3,380 5,588 –2,208
Jammer and colleagues [45] 2010 Operation 3,869 6,491 –2,622
Approximate mean or median fl uid volume per patient was approximated from data provided in individual studies (see Addition File 1 for further information). Any 
statistically signifi cantly greater administration of a component of fl uid resuscitation in goal-directed therapy (GDT) over the control group is highlighted in bold. 
aExtra volume above maintenance fl uids 500 ml/m2/day documented. bStatistically signifi cant greater fl uid administration in GDT deemed clinically insignifi cant 
(diff erence <500 ml). cCumulative fl uid balance in study through to end of surgery.
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involved GDT only in the more restrictive ﬂ uid infusion 
group (Table 2). Th e median diﬀ erence in ﬂ uid delivered 
was 2,208  ml lower (range –1,733 to –2,622  ml) in the 
treatment group (Table  3). In these three studies there 
was no clear statistical association between the volume of 
ﬂ uid therapy delivered and AKI (OR for AKI in treatment 
group = 1.68, 95% CI = 0.69 to 4.12, P = 0.26) (Figure 4 
and Table 4).
Goal-directed therapy in surgery: sensitivity analysis
We identiﬁ ed 13 studies that used more sensitive and 
comparable creatinine-based deﬁ nitions of AKI [20,22, 
25, 27,29-32,34,39,41-43], one of which [34] was excluded 
from meta-analyses due to heterogeneity. In this set of 
trials the association between GDT and protection for 
AKI was just nonsigniﬁ cant (OR = 0.61, 95% CI = 0.36 to 
1.02, P = 0.006; 12 studies, n = 1,606 patients) (Table 4). 
However, the risk of AKI was signiﬁ cantly lower in 
studies with no signiﬁ cant diﬀ erence in total ﬂ uid 
adminis tration (OR  =  0.41, 95% CI  =  0.23 to 0.71, 
P = 0.002; ﬁ ve studies, n = 861 patients) (Table 4), while 
no diﬀ erence was observed in studies with greater total 
ﬂ uid administration in GDT (OR = 0.90, 95% CI = 0.41 to 
1.97, P = 0.80; seven studies, n = 745 patients) (Table 4).
Figure 3. Meta-analysis of goal-directed therapy in surgery and risk of acute kidney injury. Meta-analysis of goal-directed therapy (GDT) in 
surgery and risk of acute kidney injury (AKI) using a random eff ects (RE) model. CI, confi dence interval.
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Discussion
Key fi ndings
In this review we have examined the evidence for the use 
of FR in improving renal outcomes during major surgery. 
We found that, on average, protocolised GDT did not 
result in signiﬁ cantly larger volumes of ﬂ uid therapy 
being administered when compared with standard 
management. Furthermore, most of the protection from 
AKI seemed to occur in studies reporting equivalent total 
quantity of ﬂ uid administration between groups. From 
this evidence, it is diﬃ  cult to ascribe beneﬁ ts of GDT 
simply to the provision of greater volumes of intravenous 
ﬂ uids to hypovolaemic patients, suggesting any eﬀ ect 
actually derived from other aspects of care. Our ﬁ ndings 
were similar when only studies using more sensitive 
creatinine-based deﬁ nitions of AKI were examined in a 
sensitivity analysis. Use of inotropes seemed to be 
associated with lower incidence of AKI with GDT and 
with the delivery of equivalent amounts of FR.
Relationship to previous studies
Conventionally, a reduction in RBF and renal ischaemia 
have been regarded central to the pathogenesis of AKI in 
critical illness [47]; however, the situation is likely to be 
more complex [48]. In animal models, AKI has been 
reported when cardiac output was preserved or elevated 
[49], and subtotal (90%) occlusion of the renal arteries did 
not lead to prolonged AKI [50]. Furthermore, cardiac 
arrest and warm renal ischaemia in humans only lead to 
signiﬁ cant AKI in the presence of severe post-resusci tation 
disease and cardiogenic shock [51]. Th ese obser vations 
infer that local and systemic inﬂ ammatory res ponses, 
Table 4. Meta-analysis for prediction of acute kidney injury with measures of heterogeneity
 Number of Odds ratio   Q-statistic
Comparison studies (95% CI) P τ2 P value I2 (%) H2
All studies conventional fl uid strategies 24 0.59 (0.39 to 0.89) 0.013 0.19 0.21 20.2 1.25
GDT involved no clinically signifi cantly  10 0.47 (0.29 to 0.76) 0.0049 0 0.73 0 1.0
greater fl uid administration
Clinically signifi cantly more fl uids  14 0.70 (0.35 to 1.41) 0.32 0.60 0.09 39.4 1.65
administered with GDT
Clinically signifi cantly more fl uids  13 0.88 (0.49 to 1.58) 0.68 0.18 0.44 16.7 1.19
administered with GDT excluding outlier study
All studies conventional fl uid strategies,  11a 0.55 (0.24 to 1.26) 0.16 0.97 0.03 52.5 2.11
no inotropes
All studies conventional fl uid strategies,  10a 0.75 (0.37 to 1.53) 0.43 0.38 0.19 30.8 1.45
no inotropes excluding outlier study
All studies conventional fl uid strategies –  14a 0.52 (0.34 to 0.80) 0.0030 0 0.87 0 1.0
inotropes in GDT
No clinically signifi cant greater fl uid  3a 0.47 (0.13 to 1.75) 0.25 0.51 0.23 37.3 1.59
administration, no inotropes
No clinically signifi cant greater fl uid  8a 0.46 (0.27 to 0.77) 0.0036 0 0.85 0 1.0
administration, inotropes in GDT
Clinically signifi cant more fl uids administered  8 0.55 (0.18 to 1.68) 0.30 1.46 0.02 60.5 2.53
with GDT, no inotropes
Clinically signifi cant more fl uids administered  7 1.0 (0.46 to 2.17) 0.99 0.19 0.26 17.2 1.21
with GDT, no inotropes excluding outlier study
Clinically signifi cant more fl uids administered  6 0.73 (0.31 to 1.69) 0.46 0.11 0.61 8.9 1.1
with GDT, inotropes in GDT
Creatinine-based defi nition of AKI excluding  12 0.61 (0.36 to 1.02) 0.06 0.20 0.23 26.6 1.36
outlier study
Creatinine-based defi nition of AKI, GDT  5 0.41 (0.23 to 0.72) 0.002 0 0.83 0 1.0
involved no clinically signifi cantly greater fl uid 
administration excluding outlier study
Creatinine-based defi nition of AKI, clinically  7 0.90 (0.41 to 1.97) 0.80 0.35 0.18 33.3 1.5
signifi cantly more fl uids administered with GDT 
excluding outlier study
GDT to assist restrictive fl uid strategy in  3 1.68 (0.69 to 4.12) 0.26 0 0.29 0 1.0
treatment arm
Statistical analysis – random eff ects model. AKI, acute kidney injury; CI, confi dence interval. aOne study presented data on goal-directed therapy (GDT) with and 
without inotropic therapy [31]. Data from these groups were considered as separate studies, dividing on the basis of use/nonuse of inotropes in GDT.
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changes in intra-RBF distribution, microcircu latory 
dysfunction and glomerular haemodynamics may all 
account for loss of kidney function, even in the presence 
of maintained or increased RBF.
Fluid administration has been shown to augment both 
cardiac output and RBF without an overall increase in 
renal oxygen delivery [52], while FR in an experimental 
model of haemorrhagic shock can restore blood pressure 
and cardiac output without recovery of renal tissue 
oxygen tension [53]. Finally, even when renal oxygen 
delivery is reduced, increased oxygen extraction may 
main tain renal oxygen consumption [54] – suggesting 
that increasing renal oxygen delivery by increasing 
cardiac output may not avert AKI.
Measurements of cardiac output are rarely made until 
critical illness is established, RBF measurements are not 
clinically available, and ﬂ uid therapy is routinely targeted 
to the treatment of arterial hypotension. Absolute or 
relative hypotension is considered a signiﬁ cant risk factor 
for the development of AKI [55,56], and lower blood 
pressure has been associated with the progression of AKI 
in sepsis [57]. However, hypotension may be related to 
low cardiac output, systemic vasodilation or a combi-
nation of both; and in the setting of systemic hypotension, 
RBF may be reduced, elevated or unchanged. As 
hypotension will only respond to FR if a meaningful 
increase in cardiac output can be obtained, this response 
may only be partial or transient in the context of systemic 
vasodilatation. Th e RBF eﬀ ect of FR for hypotension 
might thus be signiﬁ cant or negligible depending on the 
context. Bedside physiological measurements such as 
blood pressure and urine output will be even more 
indirectly related to the pathogenesis of AKI, although 
they are routine triggers for FR.
Signifi cance of study fi ndings
Any potential beneﬁ ts of FR must be weighed against the 
consequences of ﬂ uid accumulation. In acute illness, 
exogenous ﬂ uid replacement almost inevitably leads to 
positive ﬂ uid balances. Additionally, the critically ill are 
particularly susceptible to ﬂ uid overload [5]. Physio-
logically, ﬂ uid overload results in tissue oedema that may 
contribute to progressive organ dysfunction. Liberal peri-
operative ﬂ uid strategies, involving large positive ﬂ uid 
balances, have been associated with increased compli-
cations after surgery [3,4,58]. Importantly, as an encapsu-
lated organ the kidney is itself particularly aﬀ ected by 
ﬂ uid congestion, because raised venous and intra-capsular 
Figure 4. Meta-analysis of restrictive fl uid management with goal-directed therapy and risk of acute kidney injury. Meta-analysis of 
restrictive fl uid management in conjunction with goal-directed therapy and risk of acute kidney injury (AKI) using a random eff ects (RE) model. CI, 
confi dence interval.
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pressures cause signiﬁ cant decreases in RBF and the 
glomerular ﬁ ltration rate [59]. Studies examining liberal 
versus more conservative ﬂ uid management during 
surgery have failed to demonstrate an increase in AKI in 
patients receiv ing less ﬂ uid. Instead, recent analysis of 
results from the Fluid and Catheter Treatment Trial has 
shown that pursuing an even ﬂ uid balance strategy in 
patients with acute lung injury was associated with a 
lower incidence of AKI after allowing for the dilutional 
eﬀ ect of positive ﬂ uid balances on serum creatinine 
concentration [60].
GDT may thus be beneﬁ cial not only by providing extra 
ﬂ uid when it is speciﬁ cally indicated, but also by allowing 
earlier and guided use of ﬂ uids while preventing the 
delivery of unnecessary ﬂ uid when speciﬁ c and objective 
haemodynamic targets are met. Seen in this light, 
appropriate use of GDT is in harmony, rather than in 
conﬂ ict, with more restrictive approaches to peri opera-
tive ﬂ uid therapy.
We identiﬁ ed three studies that fell outside the criteria 
for inclusion in our main analysis where GDT was used 
in conjunction with ﬂ uid restriction [44-46]. Th ese 
studies moved beyond ﬂ uid optimisation using GDT to 
actively minimise perioperative maintenance ﬂ uid admi-
nis tration, resulting in signiﬁ cantly smaller ﬂ uid adminis-
tration than standard care (Table 3). No clear association 
was found between postoperative AKI and more restric-
tive ﬂ uid balances. A possible trend toward increased 
incidence of AKI with ﬂ uid restriction was seen, but 
there was signiﬁ cant heterogeneity between a small 
number of studies. In addition, relative haemodilution in 
control groups might be expected to artefactually lower 
the incidence of AKI, which was deﬁ ned by small rises in 
serum creatinine. Given that avoidance of ﬂ uid overload 
may improve wider postoperative outcomes, and that 
GDT appears to protect against AKI when compared 
with conventional ﬂ uid management, the use of GDT 
strategies to facilitate more restrictive perioperative ﬂ uid 
therapy while avoiding covert hypovolaemia merits 
further examination in larger trials.
Low-dose inotropes have been associated with better 
postoperative outcomes when used in perioperative GDT 
[61]. In our meta-analysis, use of inotropes in GDT was 
associated with a decreased risk of postoperative AKI – a 
ﬁ nding described previously [10]. Without speciﬁ c trials, 
however, it is diﬃ  cult to dissect the relative contributions 
of inotropy and ﬂ uid management on renal outcomes. 
We found that trials using inotropes in GDT and similar 
volumes of ﬂ uid therapy to controls were associated with 
the best renal outcomes, while excess ﬂ uid and no 
inotropes were associated with the worst renal outcomes. 
It is diﬃ  cult to assess the relative contributions of FR and 
inotropes, but a synergistic eﬀ ect is likely; so that goal-
directed FR may allow optimal use of inotropic drugs, 
while ino tropic drugs may maximise the haemodynamic 
eﬀ ect of ﬂ uids and reduce the risk of ﬂ uid overload. 
Notably, an important physio logical consequence of 
increased cardiac contract ility is a decrease in right atrial 
pressure, potentially a beneﬁ cial eﬀ ect limiting the 
increase in venous pressure with FR.
Are these ﬁ ndings generalisable beyond the context of 
major surgery? Sepsis is the leading cause of AKI in the 
ICU and shares many features with systemic inﬂ amma-
tory response after major surgery. In septic shock, even 
though patients tend to have high cardiac outputs, 
insensible or distributive ﬂ uid losses are common and FR 
may be required acutely. However, increased capillary 
permeability makes septic patients particularly prone to 
generalised tissue oedema and the adverse eﬀ ects of ﬂ uid 
overload. Historically, approaches targeting supranormal 
levels of cardiac output and oxygen delivery in patients 
with established critical illness (including many patients 
with severe sepsis) have been nonbeneﬁ cial [62] or 
harmful [63]. More recently, treatment protocols imme-
diately after presentation have demonstrated that target-
ing central venous oxygen saturation may improve 
survival in septic shock [64]. However, the speciﬁ c eﬀ ect 
of goal-directed resuscitation on renal function was not 
explicitly examined.
Applying a similar search strategy to that employed in 
the present systematic review to locate studies examining 
GDT for the acute treatment of septic shock, we only 
identiﬁ ed two articles documenting a renal outcome 
[65,66] – only one of which was in adult patients, pre-
cluding a useful meta-analysis in this population. Both of 
these studies showed a beneﬁ cial eﬀ ect of GDT on renal 
as well as other out comes. Signiﬁ cantly, in both studies 
GDT was associated with earlier FR in at a higher ﬂ ow 
rate than standard care, but the overall quantity of FR did 
not diﬀ er between GDT and standard care – suggesting 
that, in septic shock, early, targeted, therapy may restore 
haemodynamics and spare later ﬂ uid require ments. Th e 
same eﬀ ect  – early GDT actually being associated with 
similar ﬂ uid balances to controls over a longer period of 
treatment – was also observed by Rivers and colleagues 
in their landmark, although controversial, single-centre 
study of early GDT in septic shock [64]. By contrast, in 
the recent FEAST study of ﬂ uid management in children 
presenting with severe sepsis in Kenya, Tanzania and 
Uganda, rapid ﬂ uid bolus volume expan sion was 
associated with signiﬁ cant harm [67]; importantly, 
however, ﬂ uid therapy in the FEAST study was not 
guided by any form of invasive haemodynamic monitor-
ing. Th erefore, in the setting of septic shock as well as 
surgery, goal-directed haemodynamic resuscitation may 
be beneﬁ cial to the kidney and other organs by targeting 
FR only to those patients that require it, and avoiding 
FR in those that do not. At present, however, evidence 
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to guide choices in FR for septic shock remains very 
limited.
Strengths and limitations of review fi ndings
Th e meta-analyses performed in this review prov ide a 
basis for discussion of the beneﬁ ts of FR on renal 
function in the critically ill. Our search was conﬁ ned to 
the Pubmed electronic database and it is possible that 
relevant studies were missed; however, similar meta-
analyses with a wider database search identiﬁ ed a similar 
set of publications [8,10], while inclusion in Pubmed 
publications should ensure original studies were subject 
to independent peer review. Studies varied widely in 
populations, outcome measures and methodology, and 
conclusions from these data can only be regarded as 
hypothesis forming  – although our results were essen-
tially unchanged when considering only studies with 
more similar deﬁ nitions of AKI. GDT protocols are 
complex and it is diﬃ  cult to attribute beneﬁ t to speciﬁ c 
components of each strategy. We can hypothesise that 
GDT results in timelier FR for patients who require it, 
even if the total volume of FR within a trial does not 
diﬀ er from the standard of care. While this is probably 
true considering the nature of GDT, data provided in the 
surgical trials we considered generally did not include 
timing of ﬂ uids within the study period, so we had no 
capacity to examine this important question in our 
analysis.
We did not assess the formulation of intravenous ﬂ uids 
in these studies. Th is is a complex issue of considerable 
clinical signiﬁ cance. However, none of the studies we 
examined set out to speciﬁ cally compare diﬀ ering formu-
lations of intravenous ﬂ uid, and a variety of intravenous 
ﬂ uids were used in the treatment and control groups in 
these studies. Individual patient data would be required 
to explore the eﬀ ect of ﬂ uid formulation on renal 
outcomes in these studies. It is of course possible that 
higher volume ﬂ uid administration is associated with a 
larger volume of colloid exposure, potentially associated 
with harm to the kidney countering the beneﬁ ts of GDT, 
but assessing the size of any eﬀ ect will be very diﬃ  cult. 
Major multicentre randomised trials comparing the 
eﬀ ect of colloid versus crystalloids for FR in intensive 
care are nearing publication [68,69] and high-quality data 
regarding the formulation of FR and outcomes should 
shortly be available. When these data are available we will 
be in a much better position to assess the interaction 
between the volume of FR, the composition of intra-
venous ﬂ uids and AKI.
Our assessments of overall ﬂ uid volumes administered 
between groups in these studies are based on the mean 
or median values provided in the articles; they are 
therefore imprecise and do not provide information on 
the ﬂ uid balance, timing of ﬂ uid administration or rate of 
ﬂ uid administration. However, even though the exact 
ﬂ uid quantities and their clinical signiﬁ cance could be 
argued, we feel the general conclusion that perioperative 
GDT does not, overall, result in much additional intra-
venous ﬂ uid being administered is supported by the 
studies identiﬁ ed. We considered ﬂ uid administration 
rather than ﬂ uid balance, because ﬂ uid balances during 
GDT were only reported in a small number of studies. 
Th ree large multi centre RCTs examining the eﬀ ect of 
GDT in sepsis (ProCESS [70], ARISE [71] and ProMISe 
[72]) and another RCT examining perioperative GDT in 
high-risk surgery (OPTIMISE [73]) are ongoing. Our level 
of evidence to guide ﬂ uid therapy in complex, acute 
unwell patients should therefore increase in the next 3 to 
4  years. In the interim, current evidence suggests that 
ﬂ uid management that rapidly recognises and treats 
hypovolaemia while avoiding inappropriate ﬂ uid loading 
may be optimal for renal function and wider clinical 
outcomes.
Conclusions
Goal-directed haemodynamic therapies involving guided 
administration of intravenous ﬂ uids are associated with 
decreased incidence of AKI in the setting of major 
surgery. Evidence in sepsis is presently inconclusive. 
Crucially, the beneﬁ t of these targeted haemodynamic 
interventions does not seem to be dependent on the 
amount of ﬂ uid administered. On the contrary, GDT 
seems to achieve better kidney protection when deliver-
ing equivalent amounts of FR, perhaps by providing ﬂ uid 
earlier, faster and with the support of inotropic drugs, 
thus minimizing the harmful eﬀ ects of ﬂ uid overload.
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